|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
202 a.a.
|
 |
|
|
|
|
|
|
|
237 a.a.
|
 |
|
|
|
|
|
|
|
274 a.a.
|
 |
|
|
|
|
|
|
|
99 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
| Superseded by: |
 |
|
 |
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
2c/h-2kbm3/dev8 allogeneic complex
|
|
Structure:
|
 |
2c t cell receptor alpha chain. Chain: a, c. Synonym: 2c alpha chain. Engineered: yes. 2c t cell receptor beta chain. Chain: b, d. Synonym: 2c beta chain. Engineered: yes. H-2kbm3 mhc class i molecule heavy chain.
|
|
Source:
|
 |
Mus musculus. Mouse. Expressed in: drosophila melanogaster. Synthetic: yes. Other_details: the peptide was chemically synthesized. The peptide is naturally found in mus musculus (mouse).
|
|
Biol. unit:
|
 |
Decamer (from
)
|
|
Resolution:
|
 |
|
2.40Å
|
R-factor:
|
0.285
|
R-free:
|
0.312
|
|
|
Authors:
|
 |
J.G.Luz,M.D.Huang,K.C.Garcia,M.G.Rudolph,L.Teyton,I.A.Wilson
|
|
Key ref:
|
 |
J.G.Luz
et al.
(2002).
Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) Interactions.
J Exp Med,
195,
1175-1186.
PubMed id:
|
 |
|
Date:
|
 |
|
21-Aug-01
|
Release date:
|
15-May-02
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
No UniProt id for this chain
|
|
|
|
|
|
|
|
|
 |
 |
|
|
|
|
No UniProt id for this chain
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
J Exp Med
195:1175-1186
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural comparison of allogeneic and syngeneic T cell receptor-peptide-major histocompatibility complex complexes: a buried alloreactive mutation subtly alters peptide presentation substantially increasing V(beta) Interactions.
|
|
J.G.Luz,
M.Huang,
K.C.Garcia,
M.G.Rudolph,
V.Apostolopoulos,
L.Teyton,
I.A.Wilson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structures of the 2C/H-2K(bm3)-dEV8 allogeneic complex at 2.4 A and
H-2K(bm3)-dEV8 at 2.15 A, when compared with their syngeneic counterparts,
elucidate structural changes that induce an alloresponse. The Asp77Ser mutation
that imbues H-2K(bm3)-dEV8 with its alloreactive properties is located beneath
the peptide and does not directly contact the T cell receptor (TCR). However,
the buried mutation induces local rearrangement of the peptide itself to
preserve hydrogen bonding interactions between the peptide and the alpha(1) 77
residue. The COOH terminus of the peptide main chain is tugged toward the
alpha(1)-helix such that its presentation to the TCR is altered. These changes
increase the stability of the allogeneic peptide-major histocompatibility
complex (pMHC) complex and increase complementarity in the TCR-pMHC interface,
placing greater emphasis on recognition of the pMHC by the TCR beta-chain,
evinced by an increase in shape complementarity, buried surface area, and number
of TCR-pMHC contacting residues. A nearly fourfold increase in the number of
beta-chain-pMHC contacts is accompanied by a concomitant 64% increase in
beta-chain-pMHC shape complementarity. Thus, the allogeneic mutation causes the
same peptide to be presented differently, temporally and spatially, by the
allogeneic and syngeneic MHCs.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.K.Sewell
(2012).
Why must T cells be cross-reactive?
|
| |
Nat Rev Immunol,
12,
669-677.
|
 |
|
|
|
|
 |
O.P.Joffre,
E.Segura,
A.Savina,
and
S.Amigorena
(2012).
Cross-presentation by dendritic cells.
|
| |
Nat Rev Immunol,
12,
557-569.
|
 |
|
|
|
|
 |
S.Gras,
L.Kjer-Nielsen,
Z.Chen,
J.Rossjohn,
and
J.McCluskey
(2011).
The structural bases of direct T-cell allorecognition: implications for T-cell-mediated transplant rejection.
|
| |
Immunol Cell Biol,
89,
388-395.
|
 |
|
|
|
|
 |
A.Ziegler,
C.A.Müller,
R.A.Böckmann,
and
B.Uchanska-Ziegler
(2009).
Low-affinity peptides and T-cell selection.
|
| |
Trends Immunol,
30,
53-60.
|
 |
|
|
|
|
 |
D.M.Kranz
(2009).
Two mechanisms that account for major histocompatibility complex restriction of T cells.
|
| |
F1000 Biol Rep,
1,
0.
|
 |
|
|
|
|
 |
J.K.Archbold,
W.A.Macdonald,
S.Gras,
L.K.Ely,
J.J.Miles,
M.J.Bell,
R.M.Brennan,
T.Beddoe,
M.C.Wilce,
C.S.Clements,
A.W.Purcell,
J.McCluskey,
S.R.Burrows,
and
J.Rossjohn
(2009).
Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition.
|
| |
J Exp Med,
206,
209-219.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.Kumar,
A.Vahedi-Faridi,
W.Saenger,
A.Ziegler,
and
B.Uchanska-Ziegler
(2009).
Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity.
|
| |
Protein Sci,
18,
37-49.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
P.Kumar,
A.Vahedi-Faridi,
W.Saenger,
E.Merino,
J.A.López de Castro,
B.Uchanska-Ziegler,
and
A.Ziegler
(2009).
Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens.
|
| |
J Biol Chem,
284,
29784-29797.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.I.Godfrey,
J.Rossjohn,
and
J.McCluskey
(2008).
The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.
|
| |
Immunity,
28,
304-314.
|
 |
|
|
|
|
 |
E.J.Collins,
and
D.S.Riddle
(2008).
TCR-MHC docking orientation: natural selection, or thymic selection?
|
| |
Immunol Res,
41,
267-294.
|
 |
|
|
|
|
 |
J.K.Archbold,
W.A.Macdonald,
S.R.Burrows,
J.Rossjohn,
and
J.McCluskey
(2008).
T-cell allorecognition: a case of mistaken identity or déjà vu?
|
| |
Trends Immunol,
29,
220-226.
|
 |
|
|
|
|
 |
K.M.Armstrong,
K.H.Piepenbrink,
and
B.M.Baker
(2008).
Conformational changes and flexibility in T-cell receptor recognition of peptide-MHC complexes.
|
| |
Biochem J,
415,
183-196.
|
 |
|
|
|
|
 |
P.Marrack,
K.Rubtsova,
J.Scott-Browne,
and
J.W.Kappler
(2008).
T cell receptor specificity for major histocompatibility complex proteins.
|
| |
Curr Opin Immunol,
20,
203-207.
|
 |
|
|
|
|
 |
S.Dai,
E.S.Huseby,
K.Rubtsova,
J.Scott-Browne,
F.Crawford,
W.A.Macdonald,
P.Marrack,
and
J.W.Kappler
(2008).
Crossreactive T Cells spotlight the germline rules for alphabeta T cell-receptor interactions with MHC molecules.
|
| |
Immunity,
28,
324-334.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Bharat,
and
T.Mohanakumar
(2007).
Allopeptides and the alloimmune response.
|
| |
Cell Immunol,
248,
31-43.
|
 |
|
|
|
|
 |
C.McCarthy,
D.Shepherd,
S.Fleire,
V.S.Stronge,
M.Koch,
P.A.Illarionov,
G.Bossi,
M.Salio,
G.Denkberg,
F.Reddington,
A.Tarlton,
B.G.Reddy,
R.R.Schmidt,
Y.Reiter,
G.M.Griffiths,
P.A.van der Merwe,
G.S.Besra,
E.Y.Jones,
F.D.Batista,
and
V.Cerundolo
(2007).
The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.
|
| |
J Exp Med,
204,
1131-1144.
|
 |
|
|
|
|
 |
L.A.Colf,
A.J.Bankovich,
N.A.Hanick,
N.A.Bowerman,
L.L.Jones,
D.M.Kranz,
and
K.C.Garcia
(2007).
How a single T cell receptor recognizes both self and foreign MHC.
|
| |
Cell,
129,
135-146.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Varani,
A.J.Bankovich,
C.W.Liu,
L.A.Colf,
L.L.Jones,
D.M.Kranz,
J.D.Puglisi,
and
K.C.Garcia
(2007).
Solution mapping of T cell receptor docking footprints on peptide-MHC.
|
| |
Proc Natl Acad Sci U S A,
104,
13080-13085.
|
 |
|
|
|
|
 |
N.J.Felix,
and
P.M.Allen
(2007).
Specificity of T-cell alloreactivity.
|
| |
Nat Rev Immunol,
7,
942-953.
|
 |
|
|
|
|
 |
A.J.Bordner,
and
R.Abagyan
(2006).
Ab initio prediction of peptide-MHC binding geometry for diverse class I MHC allotypes.
|
| |
Proteins,
63,
512-526.
|
 |
|
|
|
|
 |
L.K.Ely,
T.Beddoe,
C.S.Clements,
J.M.Matthews,
A.W.Purcell,
L.Kjer-Nielsen,
J.McCluskey,
and
J.Rossjohn
(2006).
Disparate thermodynamics governing T cell receptor-MHC-I interactions implicate extrinsic factors in guiding MHC restriction.
|
| |
Proc Natl Acad Sci U S A,
103,
6641-6646.
|
 |
|
|
|
|
 |
M.G.Rudolph,
R.L.Stanfield,
and
I.A.Wilson
(2006).
How TCRs bind MHCs, peptides, and coreceptors.
|
| |
Annu Rev Immunol,
24,
419-466.
|
 |
|
|
|
|
 |
S.R.Burrows,
J.Rossjohn,
and
J.McCluskey
(2006).
Have we cut ourselves too short in mapping CTL epitopes?
|
| |
Trends Immunol,
27,
11-16.
|
 |
|
|
|
|
 |
F.E.Tynan,
D.Elhassen,
A.W.Purcell,
J.M.Burrows,
N.A.Borg,
J.J.Miles,
N.A.Williamson,
K.J.Green,
J.Tellam,
L.Kjer-Nielsen,
J.McCluskey,
J.Rossjohn,
and
S.R.Burrows
(2005).
The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.
|
| |
J Exp Med,
202,
1249-1260.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
F.E.Tynan,
S.R.Burrows,
A.M.Buckle,
C.S.Clements,
N.A.Borg,
J.J.Miles,
T.Beddoe,
J.C.Whisstock,
M.C.Wilce,
S.L.Silins,
J.M.Burrows,
L.Kjer-Nielsen,
L.Kostenko,
A.W.Purcell,
J.McCluskey,
and
J.Rossjohn
(2005).
T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I-bound peptide.
|
| |
Nat Immunol,
6,
1114-1122.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
H.Li,
S.Van Vranken,
Y.Zhao,
Z.Li,
Y.Guo,
L.Eisele,
and
Y.Li
(2005).
Crystal structures of T cell receptor (beta) chains related to rheumatoid arthritis.
|
| |
Protein Sci,
14,
3025-3038.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
I.Belda,
S.Madurga,
X.Llorà,
M.Martinell,
T.Tarragó,
M.G.Piqueras,
E.Nicolás,
and
E.Giralt
(2005).
ENPDA: an evolutionary structure-based de novo peptide design algorithm.
|
| |
J Comput Aided Mol Des,
19,
585-601.
|
 |
|
|
|
|
 |
J.L.Chen,
G.Stewart-Jones,
G.Bossi,
N.M.Lissin,
L.Wooldridge,
E.M.Choi,
G.Held,
P.R.Dunbar,
R.M.Esnouf,
M.Sami,
J.M.Boulter,
P.Rizkallah,
C.Renner,
A.Sewell,
P.A.van der Merwe,
B.K.Jakobsen,
G.Griffiths,
E.Y.Jones,
and
V.Cerundolo
(2005).
Structural and kinetic basis for heightened immunogenicity of T cell vaccines.
|
| |
J Exp Med,
201,
1243-1255.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Madurga,
I.Belda,
X.Llorà,
and
E.Giralt
(2005).
Design of enhanced agonists through the use of a new virtual screening method: application to peptides that bind class I major histocompatibility complex (MHC) molecules.
|
| |
Protein Sci,
14,
2069-2079.
|
 |
|
|
|
|
 |
M.Hülsmeyer,
M.T.Fiorillo,
F.Bettosini,
R.Sorrentino,
W.Saenger,
A.Ziegler,
and
B.Uchanska-Ziegler
(2004).
Dual, HLA-B27 subtype-dependent conformation of a self-peptide.
|
| |
J Exp Med,
199,
271-281.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.J.Miley,
I.Messaoudi,
B.M.Metzner,
Y.Wu,
J.Nikolich-Zugich,
and
D.H.Fremont
(2004).
Structural basis for the restoration of TCR recognition of an MHC allelic variant by peptide secondary anchor substitution.
|
| |
J Exp Med,
200,
1445-1454.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Pleister,
and
D.D.Eckels
(2003).
Cryptic infection and autoimmunity.
|
| |
Autoimmun Rev,
2,
126-132.
|
 |
|
|
|
|
 |
D.Housset,
and
B.Malissen
(2003).
What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity?
|
| |
Trends Immunol,
24,
429-437.
|
 |
|
|
|
|
 |
L.Kjer-Nielsen,
C.S.Clements,
A.W.Purcell,
A.G.Brooks,
J.C.Whisstock,
S.R.Burrows,
J.McCluskey,
and
J.Rossjohn
(2003).
A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity.
|
| |
Immunity,
18,
53-64.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.A.Macdonald,
A.W.Purcell,
N.A.Mifsud,
L.K.Ely,
D.S.Williams,
L.Chang,
J.J.Gorman,
C.S.Clements,
L.Kjer-Nielsen,
D.M.Koelle,
S.R.Burrows,
B.D.Tait,
R.Holdsworth,
A.G.Brooks,
G.O.Lovrecz,
L.Lu,
J.Rossjohn,
and
J.McCluskey
(2003).
A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition.
|
| |
J Exp Med,
198,
679-691.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.J.Molldrem,
K.Komanduri,
and
E.Wieder
(2002).
Overexpressed differentiation antigens as targets of graft-versus-leukemia reactions.
|
| |
Curr Opin Hematol,
9,
503-508.
|
 |
|
|
|
|
 |
L.C.Wu,
D.S.Tuot,
D.S.Lyons,
K.C.Garcia,
and
M.M.Davis
(2002).
Two-step binding mechanism for T-cell receptor recognition of peptide MHC.
|
| |
Nature,
418,
552-556.
|
 |
|
|
|
|
 |
L.Kjer-Nielsen,
C.S.Clements,
A.G.Brooks,
A.W.Purcell,
J.McCluskey,
and
J.Rossjohn
(2002).
The 1.5 A crystal structure of a highly selected antiviral T cell receptor provides evidence for a structural basis of immunodominance.
|
| |
Structure,
10,
1521-1532.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Ramos,
and
J.A.López de Castro
(2002).
HLA-B27 and the pathogenesis of spondyloarthritis.
|
| |
Tissue Antigens,
60,
191-205.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
| |